DE69526655D1 - Wässrige emulsion mit kontrollierter freisetzung - Google Patents

Wässrige emulsion mit kontrollierter freisetzung

Info

Publication number
DE69526655D1
DE69526655D1 DE69526655T DE69526655T DE69526655D1 DE 69526655 D1 DE69526655 D1 DE 69526655D1 DE 69526655 T DE69526655 T DE 69526655T DE 69526655 T DE69526655 T DE 69526655T DE 69526655 D1 DE69526655 D1 DE 69526655D1
Authority
DE
Germany
Prior art keywords
oil
weight percent
total composition
value
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69526655T
Other languages
English (en)
Other versions
DE69526655T2 (de
Inventor
S Esmail Tabibi
Robert W Mendes
Nitin P Pathak
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medicis Pediatrics Inc
Original Assignee
Medicis Pediatrics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medicis Pediatrics Inc filed Critical Medicis Pediatrics Inc
Application granted granted Critical
Publication of DE69526655D1 publication Critical patent/DE69526655D1/de
Publication of DE69526655T2 publication Critical patent/DE69526655T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Optics & Photonics (AREA)
  • Nanotechnology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Colloid Chemistry (AREA)
DE69526655T 1994-06-21 1995-06-21 Wässrige emulsion mit kontrollierter freisetzung Expired - Fee Related DE69526655T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26327794A 1994-06-21 1994-06-21
US08/491,626 US5672358A (en) 1994-06-21 1995-06-19 Controlled release aqueous emulsion
PCT/US1995/007908 WO1995035096A1 (en) 1994-06-21 1995-06-21 Controlled release aqueous emulsion

Publications (2)

Publication Number Publication Date
DE69526655D1 true DE69526655D1 (de) 2002-06-13
DE69526655T2 DE69526655T2 (de) 2002-12-05

Family

ID=26949751

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69526655T Expired - Fee Related DE69526655T2 (de) 1994-06-21 1995-06-21 Wässrige emulsion mit kontrollierter freisetzung

Country Status (11)

Country Link
US (1) US5672358A (de)
EP (1) EP0773780B1 (de)
JP (1) JP3583435B2 (de)
AT (1) ATE217186T1 (de)
AU (1) AU706516B2 (de)
CA (1) CA2193497C (de)
DE (1) DE69526655T2 (de)
DK (1) DK0773780T3 (de)
ES (1) ES2176333T3 (de)
WO (1) WO1995035096A1 (de)
ZA (1) ZA955153B (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2751222B1 (fr) * 1996-07-16 1998-10-09 Capsulis Compositions contenant au moins un acide nucleique et leurs applications dans le domaine biomedical, en particulier en therapie genique
GB9625589D0 (en) * 1996-12-10 1997-01-29 Boots Co Plc Therapeutic agents
US7541020B2 (en) * 1997-05-08 2009-06-02 Corixa Corporation Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors
US5891476A (en) * 1997-12-22 1999-04-06 Reo; Joe P. Tastemasked pharmaceutical system
US6682758B1 (en) 1998-12-22 2004-01-27 The United States Of America As Represented By The Department Of Health And Human Services Water-insoluble drug delivery system
EP1189597A4 (de) * 1999-06-04 2008-06-18 Pacira Pharmaceuticals Inc Zusammensetzungen mit einem öl-kern zur verzögerten freisetzung hydrophober arzneistoffe
US6703319B1 (en) 1999-06-17 2004-03-09 Micron Technology, Inc. Compositions and methods for removing etch residue
US7153525B1 (en) * 2000-03-22 2006-12-26 The University Of Kentucky Research Foundation Microemulsions as precursors to solid nanoparticles
EP1305008A4 (de) * 2001-03-27 2005-02-09 R P Scherer Technologies Inc A Verbesserte formen von pharmazeutischen wirkstoffen und verfahren zu deren herstellung
US20040132823A1 (en) * 2001-11-02 2004-07-08 Leo Pavliv Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid
US7763663B2 (en) * 2001-12-19 2010-07-27 University Of Massachusetts Polysaccharide-containing block copolymer particles and uses thereof
US20030139582A1 (en) * 2002-01-17 2003-07-24 Wang Kai Hua Composition containing biologically active polypeptides suitable for the oral administration
US20030232097A1 (en) * 2002-06-17 2003-12-18 Strides Inc. Oily wax matrix suspension formulation comprising ibuprofen free acid and potassium salt of ibuprofen
US20040213837A1 (en) * 2002-08-05 2004-10-28 Sankaram Mantripragada Oil-core compositions for the sustained release of hydrophobic drugs
US20060189554A1 (en) * 2002-09-24 2006-08-24 Russell Mumper Nanoparticle-Based vaccine delivery system containing adjuvant
CA2430541A1 (en) * 2003-05-30 2004-11-30 Isomers Laboratories Cosmetic
DK1680097T3 (da) * 2003-10-27 2009-07-06 Dow Corning Præparater til topisk påföring og fremgangsmåder til afgivelse af et aktivt middel til et substrat
US8318210B2 (en) * 2005-02-28 2012-11-27 Neos Therapeutics, Lp Compositions and methods of making sustained release liquid formulations
EP1879466B2 (de) * 2005-03-04 2015-05-06 DSM IP Assets B.V. Teilchenförmige nahrungsmittel-lipid-zusammensetzung
JP5368793B2 (ja) 2005-07-18 2013-12-18 ユニバーシティ オブ マサチューセッツ ロウエル ナノエマルジョンを製造および使用するための組成物および方法
AU2006291588A1 (en) * 2005-09-16 2007-03-22 Dsm Ip Assets B.V. Particulate lipid pharmaceutical composition
TR201901443T4 (tr) 2005-12-01 2019-02-21 Univ Massachusetts Lowell Botulinum nanoemülsiyonları.
US9486408B2 (en) 2005-12-01 2016-11-08 University Of Massachusetts Lowell Botulinum nanoemulsions
JP2009533471A (ja) * 2006-04-12 2009-09-17 バイオデル， インコーポレイテッド 即効型および長時間作用型組合せインスリン製剤
US20080118570A1 (en) * 2006-11-20 2008-05-22 Zhi Liu Polymer coated drug-ion exchange resins and methods
EP2494958A1 (de) 2006-12-01 2012-09-05 Anterios, Inc. Nanopartikel aus amphiphilen Einheiten
BRPI0719732A2 (pt) 2006-12-01 2017-05-16 Anterios Inc nanopartículas de peptídeo e usos para as mesmas
ES2660906T3 (es) 2007-05-31 2018-03-26 Anterios, Inc. Nanopartículas de ácido nucleico y usos de las mismas
GB201006215D0 (en) * 2010-04-14 2010-06-02 Ayanda As Composition
US20120015913A1 (en) * 2010-07-15 2012-01-19 Delansorne Remi Formulations of 14-EPI-Analogues of Vitamin D
AU2010359346B2 (en) * 2010-08-20 2015-01-29 Dr. Reddy's Laboratories Sa Phospholipid depot
JP6121796B2 (ja) * 2012-05-23 2017-04-26 キユーピー株式会社 脂肪乳剤および医薬品組成物中の非ステロイド性抗炎症薬の含有量を高める方法
KR102487144B1 (ko) 2016-11-21 2023-01-12 에이리온 테라퓨틱스, 인코포레이티드 큰 물질의 경피 전달
US11278493B2 (en) 2018-12-10 2022-03-22 EternaTear, Inc. Ophthalmic formulations providing durable ocular lubrication
US11679078B1 (en) 2022-03-08 2023-06-20 EternaTear, Inc. Ophthalmic formulations and related methods
US11471475B1 (en) 2022-03-08 2022-10-18 Ralph P. Stone Ophthalmic suspension vehicles and related methods for pharmaceutical ingredient delivery

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
US5188837A (en) * 1989-11-13 1993-02-23 Nova Pharmaceutical Corporation Lipsopheres for controlled delivery of substances
AU658608B2 (en) * 1991-03-25 1995-04-27 Astellas Pharma Europe B.V. Topical preparation containing a suspension of solid lipid particles
EP0580778B1 (de) * 1991-04-19 1999-08-11 LDS Technologies, Inc. Konvertierbare mikroemulsionsverbindungen
MX9204382A (es) * 1991-07-26 1993-08-01 Smithkline Beecham Corp Composiciones
US5576016A (en) * 1993-05-18 1996-11-19 Pharmos Corporation Solid fat nanoemulsions as drug delivery vehicles

Also Published As

Publication number Publication date
AU2907095A (en) 1996-01-15
ES2176333T3 (es) 2002-12-01
EP0773780A1 (de) 1997-05-21
US5672358A (en) 1997-09-30
DE69526655T2 (de) 2002-12-05
EP0773780A4 (de) 1998-09-30
CA2193497A1 (en) 1995-12-28
ZA955153B (en) 1996-05-07
AU706516B2 (en) 1999-06-17
WO1995035096A1 (en) 1995-12-28
ATE217186T1 (de) 2002-05-15
JP2002510279A (ja) 2002-04-02
EP0773780B1 (de) 2002-05-08
CA2193497C (en) 2000-10-17
DK0773780T3 (da) 2002-09-09
JP3583435B2 (ja) 2004-11-04

Similar Documents

Publication Publication Date Title
DE69526655D1 (de) Wässrige emulsion mit kontrollierter freisetzung
EP0656779A4 (de) Emulsionen im submikron-bereich als vehikel zur arzneistoffverabreichung am auge.
KR920017642A (ko) 고체 지질 입자의 현탁액을 함유한 국소제제
ES2186802T3 (es) Microemulsiones destinadas a usarse como vehiculos para la alimentacion de compuestos activos.
EP0041772A2 (de) Fett-Emulsion, die ein Steroid enthält
AU650946B2 (en) Analgesic compositions
FR2561916B1 (fr) Forme galenique pour administration orale et son procede de preparation par lyophilisation d'une emission huile dans eau
FR2767064B1 (fr) Procede de liberation d'un principe actif contenu dans une emulsion multiple
EP0272374A3 (de) Bioaktive Zusammensetzungen und Verfahren zu deren Herstellung und Verwendung
KR870000921A (ko) 마이크로에멀젼 조성물
GB9400981D0 (en) Preparation of microparticles
FI910674A (fi) Menetelmä mikrokapselin valmistamiseksi, josta vapautuu pidennetysti luteinisoivaa hormonia vapauttavaa hormonia
IE870283L (en) Micro emulsions
EP0284026A3 (de) Verfahren zur Zubereitung einer emulgierten Fett-Zusammensetzung
EP0626850A4 (de) Trockene zusammensetzung zur herstellung von emulsionen im submikron-bereich.
Weingarten et al. Interactions of a non-ionic ABA copolymer surfactant with phospholipid monolayers: possible relevance to emulsion stabilization
JP2001010925A5 (de)
JPS5810365B2 (ja) 脂肪乳剤
NZ227813A (en) Oil in water emulsion having 3-40% oil and an amphipathic emulsifying agent in the range 0.02-2% and method of forming such emulsions
CZ59995A3 (en) Antivirally active pharmaceutical oil-in water emulsion containing 9/(2-hydroxyethoxy)methyl/quanine (acyclovirus) or salts or esters thereof
TR199901716T2 (en) So�utucu ya�lama em�lsiyonu.
RU2005100961A (ru) Композиция эмульсий для антиперспирантов
WO2001007058A3 (en) Parenteral cisplatin emulsion
WO1996032923A3 (de) Antitranspirantien
ES2059827T3 (es) Emulsion para administracion parenteral.

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: ASCENT PEDIATRICS, INC., SCOTTSDALE, ARIZ., US

8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee